Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000210

Options or other derivatives

  • Director acquired 75.9 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Upadhyay Suketu · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-07-15 Grant or award : show line 1 in the form Deferred Stock Units +75.9 $469.34 $35,625 2,551.51 D
Loading xslF345X05/wk-form4_1752782953.xml…